About

Publications While At HealthPartners

selected publications

Journal Article

Time in range, time in tight range, and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data. 

Diabetes Technology & Therapeutics. 2024

Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice. 

Diabetes, Obesity & Metabolism. 2022

Addressing shortfalls of laboratory HbA(1c) using a model that incorporates red cell lifespan. 

eLife. 2021

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial. 

Annals of Oncology. 2016

Review

Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes [review]. 

Diabetes Technology & Therapeutics. 2024

Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator [review]. 

Diabetes Technology & Therapeutics. 2023

Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis [meta-analysis]. 

PloS One. 2013

presentations

Presentation

Individualized hemoglobin A1c: a new glycemic marker determined using continuous glucose monitoring [presentation], American Diabetes Association (ADA) 79th Scientific Sessions

Contact

full name

Y. Xu

Quick Info

 

Collaboration

Co-author network

Map of science